Commonwealth Equity Services’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $12.4M | Sell |
|
|||||
|
2025
Q2 | $10.2M | Sell |
|
|||||
|
2025
Q1 | $11.1M | Sell |
|
|||||
|
2024
Q4 | $13.7M | Buy |
|
|||||
|
2024
Q3 | $11.2M | Buy |
|
|||||
|
2024
Q2 | $9.89M | Sell |
|
|||||
|
2024
Q1 | $10.8M | Sell |
|
|||||
|
2023
Q4 | $16.9M | Sell |
|
|||||
|
2023
Q3 | $14.2M | Buy |
|
|||||
|
2023
Q2 | $10.3M | Sell |
|
|||||
|
2023
Q1 | $9.8K | Buy |
|
|||||
|
2022
Q4 | $7.74M | Sell |
|
|||||
|
2022
Q3 | $7.98M | Sell |
|
|||||
|
2022
Q2 | $9.28M | Buy |
|
|||||
|
2022
Q1 | $9.13M | Sell |
|
|||||
|
2021
Q4 | $12.4M | Buy |
|
|||||
|
2021
Q3 | $11.8M | Sell |
|
|||||
|
2021
Q2 | $13.2M | Sell |
|
|||||
|
2021
Q1 | $19.9M | Buy |
|
|||||
|
2020
Q4 | $17.1M | Buy |
|
|||||
|
2020
Q3 | $13.1M | Sell |
|
|||||
|
2020
Q2 | $17.4M | Buy |
|
|||||
|
2020
Q1 | $9.55M | Buy |
|
|||||
|
2019
Q4 | $11.4M | Sell |
|
|||||
|
2019
Q3 | $10.6M | Buy |
|
|||||
|
2019
Q2 | $10.6M | Buy |
|
|||||
|
2019
Q1 | $9.4M | Sell |
|
|||||
|
2018
Q4 | $7.71M | Buy |
|
|||||
|
2018
Q3 | $9.69M | Buy |
|
|||||
|
2018
Q2 | $8.15M | Sell |
|
|||||
|
2018
Q1 | $10.4M | Buy |
|
|||||
|
2017
Q4 | $7.22M | Buy |
|
|||||
|
2017
Q3 | $5.93M | Buy |
|
|||||
|
2017
Q2 | $3.9M | Sell |
|
|||||
|
2017
Q1 | $3.75M | Sell |
|
|||||
|
2016
Q4 | $3.35M | Buy |
|
|||||
|
2016
Q3 | $2.95M | Sell |
|
|||||
|
2016
Q2 | $2.49M | Buy |
|
|||||
|
2016
Q1 | $1.93M | Sell |
|
|||||
|
2015
Q4 | $2.9M | Sell |
|
|||||
|
2015
Q3 | $2.58M | Sell |
|
|||||
|
2015
Q2 | $4.59M | Buy |
|
|||||
|
2015
Q1 | $3.48M | Buy |
|
|||||
|
2014
Q4 | $2.31M | Buy |
|
|||||
|
2014
Q3 | $1.78M | Sell |
|
|||||
|
2014
Q2 | $1.9M | Sell |
|
|||||
|
2014
Q1 | $1.94M | Buy |
|
|||||
|
2013
Q4 | $1.71M | Sell |
|
|||||
|
2013
Q3 | $2.06M | Buy |
|
|||||
|
2013
Q2 | $1.14M | Buy |
|